Search

Noble E. Jarrell

Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )

Most Active Art Unit
1699
Art Unit(s)
1624, 1622, 1625, 1699, 1609, 1629
Total Applications
1459
Issued Applications
965
Pending Applications
172
Abandoned Applications
340

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15345135 [patent_doc_number] => 20200010459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => PIPERAZINE DERIVATIVES FOR INFLUENZA VIRUS INHIBITIONS [patent_app_type] => utility [patent_app_number] => 16/483283 [patent_app_country] => US [patent_app_date] => 2018-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483283 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/483283
Piperazine derivatives for influenza virus inhibitions Jan 31, 2018 Issued
Array ( [id] => 16696619 [patent_doc_number] => 10947199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders [patent_app_type] => utility [patent_app_number] => 16/481562 [patent_app_country] => US [patent_app_date] => 2018-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 2636 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481562 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/481562
Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders Jan 29, 2018 Issued
Array ( [id] => 15293475 [patent_doc_number] => 20190389873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => DEUTERATED COMPOUND AND MEDICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/484058 [patent_app_country] => US [patent_app_date] => 2018-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484058 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/484058
Deuterated compound and medical use thereof Jan 25, 2018 Issued
Array ( [id] => 15290579 [patent_doc_number] => 20190388425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => SUBSTITUTED IMIDAZOPYRIDINPYRIMIDINES [patent_app_type] => utility [patent_app_number] => 16/479400 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479400 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/479400
SUBSTITUTED IMIDAZOPYRIDINPYRIMIDINES Jan 18, 2018 Abandoned
Array ( [id] => 16807786 [patent_doc_number] => 20210130339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/480839 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480839 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480839
COMPOUNDS Jan 18, 2018 Abandoned
Array ( [id] => 16125811 [patent_doc_number] => 10696645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-30 [patent_title] => Method for producing purified dialkyl-furan-2,5-dicarboxylate [patent_app_type] => utility [patent_app_number] => 15/875352 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17160 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875352 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/875352
Method for producing purified dialkyl-furan-2,5-dicarboxylate Jan 18, 2018 Issued
Array ( [id] => 14057757 [patent_doc_number] => 10233162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-19 [patent_title] => Electronically activated strained alkynes [patent_app_type] => utility [patent_app_number] => 15/873984 [patent_app_country] => US [patent_app_date] => 2018-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5792 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873984 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/873984
Electronically activated strained alkynes Jan 17, 2018 Issued
Array ( [id] => 12837340 [patent_doc_number] => 20180170953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/866669 [patent_app_country] => US [patent_app_date] => 2018-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866669 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/866669
Prototype systems of theranostic biomarkers for in vivo molecular management of cancer Jan 9, 2018 Issued
Array ( [id] => 15775501 [patent_doc_number] => 20200118768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => COMPOSITIONS AND METHODS OF MAKING METAL-ORGANIC FRAMEWORKS WITH REDOX-ACTIVE CENTERS [patent_app_type] => utility [patent_app_number] => 16/471812 [patent_app_country] => US [patent_app_date] => 2017-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7661 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471812 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/471812
Compositions and methods of making metal-organic frameworks with redox-active centers Dec 28, 2017 Issued
Array ( [id] => 15086231 [patent_doc_number] => 20190337926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => BMP-SIGNAL-INHIBITING COMPOUND [patent_app_type] => utility [patent_app_number] => 16/473850 [patent_app_country] => US [patent_app_date] => 2017-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 705 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473850 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/473850
BMP-signal-inhibiting compound Dec 25, 2017 Issued
Array ( [id] => 17036630 [patent_doc_number] => 20210253588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT [patent_app_type] => utility [patent_app_number] => 16/471237 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79766 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471237 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/471237
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment Dec 19, 2017 Issued
Array ( [id] => 13300107 [patent_doc_number] => 20180201590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => AZOCANE AND AZONANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS [patent_app_type] => utility [patent_app_number] => 15/848639 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848639 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/848639
Azocane and azonane derivatives and methods of treating hepatitis B infections Dec 19, 2017 Issued
Array ( [id] => 16743258 [patent_doc_number] => 10968232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Antidiabetic spirochroman compounds [patent_app_type] => utility [patent_app_number] => 16/465156 [patent_app_country] => US [patent_app_date] => 2017-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 858 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465156 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/465156
Antidiabetic spirochroman compounds Dec 14, 2017 Issued
Array ( [id] => 12641103 [patent_doc_number] => 20180105532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => HETEROCYCLIC COMPOUNDS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 15/841153 [patent_app_country] => US [patent_app_date] => 2017-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841153 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/841153
HETEROCYCLIC COMPOUNDS AND THEIR USES Dec 12, 2017 Abandoned
Array ( [id] => 16381927 [patent_doc_number] => 10806737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-20 [patent_title] => Compounds and methods for the targeted degradation of fetal liver kinase polypeptides [patent_app_type] => utility [patent_app_number] => 15/840950 [patent_app_country] => US [patent_app_date] => 2017-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 69734 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 883 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840950 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/840950
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides Dec 12, 2017 Issued
Array ( [id] => 15813941 [patent_doc_number] => 10632127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Targeted notch pathway inhibitors [patent_app_type] => utility [patent_app_number] => 15/837199 [patent_app_country] => US [patent_app_date] => 2017-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 16097 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837199 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/837199
Targeted notch pathway inhibitors Dec 10, 2017 Issued
Array ( [id] => 17556031 [patent_doc_number] => 11312707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-26 [patent_title] => Compositions and methods for the treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 16/464377 [patent_app_country] => US [patent_app_date] => 2017-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12396 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464377 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/464377
Compositions and methods for the treatment of fungal infections Nov 23, 2017 Issued
15/574097 ENHANCED ANTIBIOTIC COMPOSITION Nov 13, 2017 Abandoned
Array ( [id] => 16253857 [patent_doc_number] => 20200263231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => Fluorogenic dyes for high sensitivity DNA detection [patent_app_type] => utility [patent_app_number] => 16/340373 [patent_app_country] => US [patent_app_date] => 2017-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340373 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/340373
Fluorogenic dyes for high sensitivity DNA detection Oct 31, 2017 Abandoned
Array ( [id] => 14836129 [patent_doc_number] => 20190276465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => Nitrogen-Containing Heterocyclic Compounds As FXR Modulators [patent_app_type] => utility [patent_app_number] => 16/346807 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23783 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 345 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/346807
Nitrogen-containing heterocyclic compounds as FXR modulators Oct 26, 2017 Issued
Menu